HDAC9 and breast neoplasm: The decreased ERα expression in MCF7 cells upon HDAC9 overexpression, even at moderate levels, may be one of the mechanisms by which deregulated HDAC9 expression is linked to OHTam resistance in ERα‐positive breast tumor cells.